The World Health Organization (WHO) published its first clinical guidelines on the diagnosis and treatment of type 1 diabetes in adults on November 14, 2026, as part of World Diabetes Day. As reported on the official portal who.int, the new standards are intended to help 9.5 million people suffering from this disease.
Key provisions of the initiative
The presented document contains 14 recommendations based on evidence-based medicine. WHO experts emphasize that these standards are adapted for various healthcare settings, including countries with limited resources, as well as emergency and humanitarian crisis zones.
The organization identifies an intensified insulin regimen through multiple daily injections as a key aspect of therapy. Drug dosage should be adjusted based on the patient's current blood glucose levels. At the same time, WHO notes the effectiveness and economic accessibility of human insulin for widespread use.
These recommendations are aimed at overcoming barriers that prevent access to quality and affordable medical care in various countries, said Dr. Søren Brostrøm, Director of the WHO Department of Noncommunicable Diseases and Mental Health.
This initiative is part of a global strategy aimed at ensuring universal access to life-saving insulin and glucose monitoring tools by 2030. The new protocols are intended to standardize treatment approaches and improve the quality of life for patients worldwide.